Northbrook, IL -- (SBWIRE) -- 09/09/2021 -- The Dietary Supplements Market size is estimated to be valued at USD 136.2 billion in 2020 and projected to reach USD 204.7 billion by 2026, recording a CAGR of 7.0% during the forecast period.

The demand for dietary supplements is increasing significantly owing to rising prevalence of chronic diseases and changing dietary habits of the consumers. Increasing consumer health awareness and rising disposable income across regions are factors that have encouraged people to shift to dietary supplements. The elderly population is focusing on adapting to nutritional supplements specifically tailored to their needs to maintain their good health and quality of life.

Download PDF Brochure

The adult segment, by target customer is projected to witness significant growth during the forecast period.

The deficiency of certain vitamins in adults is one of the key factors that have led to the rise in the consumption of dietary supplements among adults. According to National Health and Nutrition Examination Survey, in 2016, nearly 150 million Americans consume dietary supplements, out of which, among adults, 44% of men and 55% of women are the consumers. This is projected to drive the demand for dietary supplements among adults.

The North American region dominates the dietary supplements market with the largest share in 2020.

North America is projected to hold the largest share in the dietary supplements market. This dominance is driven by the prevalence of chronic diseases due to the hectic lifestyles and increasing awareness among consumers regarding the health benefits of the product. Also, the region has the highest prevalence of obesity. According to the CDC, in the US, the obesity prevalence was 39.8% and affected about 93.3 million adults between 2015 and 2016. Such factors are projected to contribute to the growth of dietary supplements market.

Make an Inquiry

Leading companies are Amway (US), Herbalife Nutrition (US), ADM (US), Pfizer (US), Abbott Laboratories (US), Arkopharma Laboratories (France), Bayer (Germany), Glanbia (Ireland), Nature's Sunshine Products (US), FANCL (Japan), Danisco (Denmark), Bionova Lifesciences (India), XanGo (US), Ekomir (Russia), American Health (US), Pure Encapsulations (US), UST Manufacturing (US), Capstone Nutrition (US), Anona GmBH (Germany), Plantafood Medical GmBH (Germany).

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441